Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

5.60USD
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
$5.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,933
52-wk High
$7.50
52-wk Low
$3.58

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 1.33
Year Ending Dec-19 5 0.00 0.00 0.00 9.07
Earnings (per share)
Quarter Ending Dec-18 4 -0.31 -0.29 -0.33 --
Quarter Ending Mar-19 2 -0.29 -0.28 -0.31 --
Year Ending Dec-18 4 -1.33 -1.29 -1.35 -0.88
Year Ending Dec-19 5 -1.00 -0.85 -1.26 -0.84
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.36 29.34
P/E High - Last 5 Yrs. -- 265.87 45.80
P/E Low - Last 5 Yrs. -- 84.08 25.31
Beta -- 0.73 0.91
Price to Sales (TTM) -- 217.50 20.58
Price to Book (MRQ) -- 16.40 4.23
Price to Tangible Book (MRQ) -- 20.76 12.86
Price to Cash Flow (TTM) -- 48.38 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 147.95 6.76
Sales (TTM) vs TTM 1 Yr. Ago -- 61.16 5.37
Sales - 5 Yr. Growth Rate -- 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 79.14 28.07
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 20.47 7.61
Capital Spending - 5 Yr. Growth Rate -- 34.50 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.60
Current Ratio (MRQ) -- 6.52 3.62
LT Debt to Equity (MRQ) -- 18.23 9.93
Total Debt to Equity (MRQ) -- 24.16 13.84
Interest Coverage (TTM) -- -167.47 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.56 52.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -157.37 16.18
Operating Margin (TTM) -- -1,765.04 -12.21
Operating Margin - 5 Yr. Avg. -- -170.51 11.72
Pre-Tax Margin (TTM) -- -1,697.73 -10.76
Pre-Tax Margin - 5 Yr. Avg. -- -173.18 12.03
Net Profit Margin (TTM) -- -1,693.59 -14.16
Net Profit Margin - 5 Yr. Avg. -- -173.54 8.28
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.72 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,455,577 843,943,000
Net Income/Employee (TTM) -- -3,607,776 98,316,608
Receivable Turnover (TTM) -- 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) -- 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.72 10.84
Return on Assets - 5 Yr. Avg. -- 2.40 11.60
Return on Investment (TTM) -- -0.30 13.58
Return on Investment - 5 Yr. Avg. -- 2.31 14.86
Return on Equity (TTM) -- -2.98 15.11
Return on Equity - 5 Yr. Avg. -- -1.50 16.02
Note: Units in Millions of US Dollars

Performance for Intec Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.